BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17826101)

  • 21. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
    Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
    Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
    Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors: purification and inhibition studies of pigeon (Columba livia var. domestica) red blood cell carbonic anhydrase with sulfonamides.
    Ozensoy O; Arslan M; Supuran CT
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):749-53. PubMed ID: 21476925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides.
    Vullo D; Luca VD; Scozzafava A; Carginale V; Rossi M; Supuran CT; Capasso C
    Bioorg Med Chem; 2013 Mar; 21(6):1534-8. PubMed ID: 22883029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions.
    Nishimori I; Minakuchi T; Onishi S; Vullo D; Cecchi A; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):70-6. PubMed ID: 18618322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
    Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
    J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
    Truppo E; Supuran CT; Sandomenico A; Vullo D; Innocenti A; Di Fiore A; Alterio V; De Simone G; Monti SM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1560-4. PubMed ID: 22277279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
    Joseph P; Turtaut F; Ouahrani-Bettache S; Montero JL; Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Köhler S; Winum JY; Supuran CT
    J Med Chem; 2010 Mar; 53(5):2277-85. PubMed ID: 20158185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The extremo-α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides.
    Vullo D; De Luca V; Scozzafava A; Carginale V; Rossi M; Supuran CT; Capasso C
    Bioorg Med Chem; 2013 Aug; 21(15):4521-5. PubMed ID: 23777827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.
    Chazalette C; Masereel B; Rolin S; Thiry A; Scozzafava A; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5781-6. PubMed ID: 15501040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
    Joseph P; Ouahrani-Bettache S; Montero JL; Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Winum JY; Köhler S; Supuran CT
    Bioorg Med Chem; 2011 Feb; 19(3):1172-8. PubMed ID: 21251841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes.
    Koz Ö; Ekinci D; Perrone A; Piacente S; Alankuş-Çalişkan Ö; Bedir E; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):412-7. PubMed ID: 22299585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.
    Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5769-73. PubMed ID: 15501038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.